Shu Ping Gao
Voorzitter bij Hebei Hanlin Biotechnology Co., Ltd.
Profiel
Shu Ping Gao is currently the Chairman at Hebei Hanlin Biotechnology Co., Ltd.
and a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
In the past, Gao worked as a Director at SSY Group Ltd.
from 2009 to 2012 and as a Director & Vice General Manager at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Gao completed an undergraduate degree at Hebei University of Science & Technology.
Actieve functies van Shu Ping Gao
| Bedrijven | Functie | Begin |
|---|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Bestuurslid | 25-03-2010 |
Hebei Hanlin Biotechnology Co., Ltd.
 Hebei Hanlin Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Hanlin Biotechnology Co. Ltd. engages in the manufacture of biotechnological products. It offers custom peptide synthesis, secondary, monoclonal and polyclonal antibodies, cell culture medium, and custom antibody-related services. The company was founded on February 25, 2011 and is headquartered in Shijiazhuang, China. | Voorzitter | - |
Eerdere bekende functies van Shu Ping Gao
| Bedrijven | Functie | Einde |
|---|---|---|
| SSY GROUP LIMITED | Directeur/Bestuurslid | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Directeur/Bestuurslid | - |
Opleiding van Shu Ping Gao
| Hebei University of Science & Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
Hebei Hanlin Biotechnology Co., Ltd.
Hebei Hanlin Biotechnology Co., Ltd. BiotechnologyHealth Technology Hebei Hanlin Biotechnology Co. Ltd. engages in the manufacture of biotechnological products. It offers custom peptide synthesis, secondary, monoclonal and polyclonal antibodies, cell culture medium, and custom antibody-related services. The company was founded on February 25, 2011 and is headquartered in Shijiazhuang, China. | Health Technology |
